Organization of Regulatory and Clinical Associates
P.O. Box 3490
Redmond, WA 98073
Report finds mismatch in FDA, NIH stem cell line standards - from ORCA Board Member, Erica C. Jonlin, Phd
A new report shows that many National Institutes of Health-registered stem cell lines used by academics are not fit for commercial use as the donors were not screened for various diseases, which is an FDA requirement for human-derived products. The author, Erica Jonlin, notes the FDA could make an exception to allow clinical use of the federally funded stem cells. The agencies could allow testing of the cell lines, instead of the donors -- a costly move -- to address the mismatch in the NIH and FDA standards, she said. Find more at The Scientist online (02/06/14)
AMEX is now being accepted, even though the AMEX logo does not appear in the secure payment page.
We appreciate your patience while we worked on getting this resolved.
Charles Breen Farewell
Deborah Elvins and Erica Jonlin presenting Charles Breen with a Certificate of Appreciation for his outstanding contributions to ORCA. Picture taken during the July monthly meeting.
Copyright © 2011 ORCA. All rights reserved.
TUESDAY, March 11, 2014
IL-17 and IL-23: Targets with Complex Underlying Biology
Wayne Tsuji, MD, Amgen
NOTE: NO presentation materials will be posted for this meeting